Amexdrug Financial Statements
Amexdrug Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Amexdrug Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 6.1 | 4.7 | 4.9 |
| Gross Profit ($ mil.) | 0.4 | 0.4 | 0.3 |
| Operating Income ($ mil.) | (0.1) | 0.0 | 0.0 |
| Total Net Income ($ mil.) | 0.0 | 0.0 | 0.0 |
| Diluted EPS (Net Income) | -- | -- | -- |
Amexdrug Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.64 | 0.50 | 1.56 |
| Price/Earnings Ratio | -- | 13.72 | 15.82 |
| Price/Book Ratio | 144.72 | 1.75 | 1.52 |
| Price/Cash Flow Ratio | -- | 9.41 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Amexdrug Financial Ratios
Amexdrug Competitive Intelligence
| AmerisourceBergen | Cardinal Health | McKesson | |
|---|---|---|---|
| Annual Sales ($ mil.) | 66,074.3 | 86,852.0 | 101,703.0 |
| Employees | 11,300 | -- | 32,900 |
| Market Cap ($ mil.) | 6,701.0 | 19,818.3 | 15,561.4 |
Competitive Landscape
